Fluconazole Evolugen

Quick links

Choose a section

Quick links to important sections

Advertisements

Fluconazole Evolugen

Advertisements

Overview of Fluconazole Evolugen

What is Fluconazole Evolugen?

Fluconazole Evolugen is a pharmaceutical medication classified as an antifungal agent. It belongs to a specific class of drugs known as triazoles. This medication is primarily utilized to address various types of fungal and yeast infections throughout the body.

Mechanism of Action

The active ingredient, fluconazole, works by interfering with the ability of fungi to reproduce. It targets the synthesis of ergosterol, which is a vital component of the fungal cell membrane. By disrupting the formation of this membrane, the medication causes holes to appear in the cell wall, eventually leading to the death of the fungus or preventing its further growth.

Therapeutic Use

Fluconazole Evolugen is commonly used for infections caused by Candida yeasts or other fungal pathogens. These infections can occur in different areas, including:

  • Mucosal surfaces: Such as infections of the mouth, throat, or esophagus.
  • Systemic infections: More serious fungal infections that may affect the bloodstream or internal organs.
  • Skin and nail infections: Including conditions like athlete's foot or ringworm.
  • Genital infections: Specifically vaginal or fungal infections of the penis.

Characteristics

As a generic version of fluconazole, this medication contains the same active substance as the original brand-name formulations. It is designed to provide the same therapeutic effect and is available in various strengths and forms, such as capsules, to suit different clinical needs. Its systemic nature allows it to be absorbed into the bloodstream, making it effective for infections located in many different parts of the body.

Regulatory References

  1. FDA as an Antifungal Agent
Advertisements

What side effects are possible with Fluconazole Evolugen?

Possible Side Effects and Safety Information

The official safety profile of Fluconazole Evolugen is established through clinical trials and post-marketing surveillance, classifying adverse reactions primarily by frequency and the System-Organ Class (SOC) affected. The most frequently documented events are classified as Common, affecting the digestive and nervous systems.


Common and Uncommon Reactions

The most Common adverse reactions listed in regulatory documents include headache, nausea, abdominal pain, and diarrhea. Additionally, certain increases in liver enzymes (ALT, AST) are frequently observed. Reactions documented as Uncommon include dizziness, seizures, dyspepsia (indigestion), and various skin disturbances like rash and pruritus.


Serious Adverse Reactions and Systemic Risk

Fluconazole is associated with rare but potentially life-threatening Serious Adverse Reactions (SARs). These include severe liver toxicity, which in rare instances has been fatal, and serious skin reactions such as Stevens-Johnson syndrome and Toxic Epidermal Necrolysis. Risk to the cardiac system is documented by reports of QT interval prolongation and Torsades de pointes, particularly in individuals with pre-existing heart conditions or electrolyte imbalances. Severe allergic reactions (Anaphylaxis) and changes in blood cell counts (e.g., leucopenia, agranulocytosis) are also officially documented.


Population-Specific Safety Considerations

The medicine's safety profile includes specific constraints for certain populations. The use of Fluconazole is generally restricted during pregnancy due to documented risks, including a potential increased risk of spontaneous abortion and a pattern of congenital abnormalities associated with chronic, high-dose exposure during the first trimester. Caution and monitoring are advised for elderly patients and those with existing renal or hepatic impairment, as their ability to clear the medicine may be reduced.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Fluconazole overdose details specific acute manifestations and the mandated emergency response. Documented presentations of acute toxicity have included hallucinations and paranoid behavior as central nervous system effects. Severe or life-threatening outcomes include the potential for seizures and serious cardiac arrhythmias, specifically QT prolongation on the electrocardiogram and Torsades de Pointes (TdP).


When Immediate Medical Help is Required

Immediate medical help is required upon suspicion of overdose. Regulatory guidance explicitly states to seek immediate medical attention. If an individual has collapsed, had a seizure, has trouble breathing, or can't be awakened, emergency services (911) must be contacted immediately. Additionally, the poison control helpline should be called for immediate advice.

Management of overdose is limited to symptomatic treatment and supportive measures, as no specific antidote is known. Procedures such as gastric lavage may be instituted if clinically indicated following an oral overdose. Hemodialysis is documented as a measure to reduce systemic concentration; a three-hour session reduces the drug's plasma levels by approximately fifty percent. Patients with impaired renal function face an increased risk of toxicity due to slower clearance.

Advertisements

Therapeutic Uses of Fluconazole Evolugen

Fluconazole Evolugen is commonly used to address fungal and yeast infections across relevant therapeutic domains. It may assist with supportive symptomatic relief and infection management, and is applied in clinical settings where symptoms are driven by fungal proliferation, rather than bacterial or viral causes.


The medicine is applied in addressing symptom manifestations commonly associated with conditions like vulvovaginal candidiasis, oral and esophageal thrush, and serious systemic mycoses such as candidemia and Cryptococcal Meningitis. It also is applied preventatively (prophylaxis) to support patients facing high risk due to conditions like HIV/AIDS or treatments like chemotherapy. The primary benefit may include managing the infection source, which in turn helps ease symptoms related to physical discomfort and distress.

“Fluconazole is considered relevant for managing infections that range from common mucosal discomfort to serious conditions requiring strong systemic support.”


Quick Fact: Relief for Localized and Systemic Discomfort

This medication may assist with managing symptom clusters that create noticeable physiological strain, such as severe burning and itching from mucosal infections or the persistent fever and malaise associated with invasive fungal illness. It contributes to improved comfort during these periods of heightened symptoms and assists with maintaining functional stability.

Regulatory References

  1. FLUCONAZOLE tablet - DailyMed - NIH
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Fluconazole Evolugen?

Eligibility for Fluconazole Evolugen is strictly defined by regulatory documents, classifying populations into allowed, restricted, or contraindicated groups.


Contraindicated Populations (Absolute Non-Eligibility)

Individuals must not use this medicine if they have a known hypersensitivity to Fluconazole or other azole antifungals. Use is also strictly prohibited when receiving specific concomitant medications, including Cisapride, Pimozide, and Quinidine, due to documented risks of severe cardiac events. The use of Fluconazole at high, multiple doses is contraindicated with Terfenadine.


Populations Requiring Conditional or Restricted Use

Population Group Eligibility Status Primary Restriction Basis
Renal Impairment Conditional Use Requires adjustment of the maintenance regimen
Hepatic Impairment Restricted Use Requires careful monitoring for liver dysfunction
Pregnant Women Not Recommended Reserved only for serious or life-threatening infections
Lactating Women Not Recommended Passes into breast milk, especially with high doses
Pediatrics Conditional/Restricted Not recommended for specific superficial fungal infections

Eligibility Criteria

Use is established and generally permitted for adults and for specific infections in pediatric populations, including neonates, when administered under conditional protocols. In older adults, eligibility requires the assessment of renal function prior to use. Patients with uncorrected electrolyte disturbances (e.g., hypokalemia) have restricted eligibility and must have these conditions addressed first.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Fluconazole Evolugen (Fluconazole) is defined by its effects on the metabolism of co-administered medicines, primarily through enzyme inhibition, and specific restrictions documented in regulatory labeling.

Fluconazole is officially documented as a potent inhibitor of CYP2C9 and a moderate inhibitor of CYP3A4 and CYP2C19. This pharmacokinetic interaction can lead to a documented increase in the plasma concentration of numerous co-administered drugs.

Formal Contraindicated Combinations

Co-administration is formally contraindicated with medicines such as Cisapride, Pimozide, Astemizole, Quinidine, and Erythromycin due to the high risk of increased plasma levels and documented cardiotoxicity or QT prolongation.

Type of Interacting Medicine Official Regulatory Outcome
Anticoagulants (e.g., Warfarin) Increased risk of bleeding (elevated prothrombin time).
Immunosuppressants (e.g., Cyclosporine) Increased plasma concentrations of the immunosuppressant.
Statins (e.g., Simvastatin) Increased risk of myopathy/rhabdomyolysis.

Co-administration with Rifampicin is documented to reduce Fluconazole exposure (AUC). Conversely, co-administration with Hydrochlorothiazide is documented to increase Fluconazole exposure due to altered renal clearance. The official label advises caution regarding the co-administration of alcohol due to the potential for increased risk of liver damage. No clinically significant interaction is documented with food or antacids.

Advertisements

Mechanism of Action

Fluconazole Evolugen operates by specifically disrupting the synthesis pathway of essential fungal cell components, which results in a fungistatic consequence characterized by the arrest of proliferation. The mechanism exhibits selectivity, focusing only on processes unique to the fungal organism.


Targeted Inhibition of Fungal Sterol Biosynthesis

Fluconazole is a selective enzyme inhibitor that targets Lanosterol 14alpha-demethylase (14alpha-DM), a cytochrome P450 enzyme ( CYP51) found exclusively in fungi. By binding to the heme iron of this enzyme, the drug blocks the conversion of lanosterol into ergosterol, the fungal equivalent of cholesterol.


Compromise of Cell Membrane Structure and Function

The molecular block of the 14alpha-DM enzyme initiates a cascade where the fungal cell suffers ergosterol depletion and the simultaneous accumulation of toxic, non-functional 14alpha-methylated sterols. This compromised lipid composition severely damages the cell membrane structure, increasing its permeability and fluidity. This physiological failure impairs the fungus's ability to maintain structural integrity and execute growth and reproduction.

Advertisements

Dosage and Administration Information

Fluconazole is an antifungal medication, available in forms such as tablets, oral suspension, and injection, used to treat various fungal and yeast infections. Proper administration is crucial to ensure efficacy and reduce the risk of drug-resistant infections.

General Administration

  • Dosage: Your doctor determines the dose and duration of treatment based on the type and severity of the infection. Do not take more or less of the medication than prescribed.
  • Food Intake: The oral tablet and suspension forms of Fluconazole can generally be taken with or without food, as its absorption is not significantly affected.
  • Timing: For multi-day regimens, take the dose at approximately the same time each day to maintain consistent drug levels in the bloodstream. A single-dose regimen (e.g., for vaginal candidiasis) is typically a 150 mg capsule taken just once.

Completing the Course

  • It is essential to complete the full course of Fluconazole therapy as prescribed, even if symptoms begin to improve or disappear quickly. Stopping the medication prematurely may allow the infection to return and potentially develop resistance.
  • If you forget a dose, take it as soon as you remember unless it is nearly time for your next scheduled dose. In this case, skip the missed dose and resume your regular schedule. Do not take a double dose to compensate for a missed one.

Specific Form Instructions

  • Oral Suspension: Shake the liquid well before each use. Always use a calibrated measuring device, such as a dosing syringe or a marked spoon, to accurately measure the dose. Do not use an ordinary kitchen teaspoon.
Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Fluconazole Evolugen

The research evidence for Fluconazole Evolugen is derived from clinical studies, including controlled trials and reviews, that explore its role in the management of several fungal infections. These studies focus on the study of its use in different research settings, which patient groups were included in the research, and what limitations or uncertainties remain.


Evidence for Use in Common Mucosal Infections

Research examining this medicine's role in conditions such as vulvovaginal candidiasis (VVC) and oral/esophageal candidiasis (thrush) has been the subject of multiple Randomized Controlled Trials (RCTs) and systematic reviews. Regulatory bodies classify the evidence base for these uses as High Level.

Studies related to VVC often measured clinical resolution (disappearance of signs and symptoms) and mycological clearance (laboratory confirmation of fungal removal). For the prevention of recurrent VVC, longer-term trials were applied in studies examining patient-reported experiences to see how often and how quickly new episodes developed. For oral and esophageal candidiasis, studies primarily examined clinical outcomes reflecting daily functioning, such as the ability to swallow without pain, alongside mycological clearance.


Evidence for Use in Systemic and Serious Fungal Infections

Research exploring Fluconazole Evolugen in more serious, systemic fungal infections—including candidemia (fungus in the bloodstream) and cryptococcal meningitis— was evaluated in comparative studies, often alongside other antifungal agents.

For candidemia, research was studied for its use in patient groups who were not critically ill or in those who were clinically stable after initial aggressive therapy protocols. Outcomes monitored included fungal clearance from the bloodstream and measurements of patient status over defined time intervals. This evidence is generally characterized as Moderate to High Level, though results apply only to the populations studied.

For cryptococcal meningitis, research was observed in studies primarily focusing on immunocompromised patients. The evidence for consolidation and maintenance phases was observed in trials described in international guidelines that classify the research as High Level.


Evidence Gaps and Areas of Scientific Uncertainty

While the medicine was studied for various indications, research highlights certain areas where data are still emerging. Studies indicate that the medicine appears to have less activity against certain non-albicans Candida species, such as C. krusei. Findings were mixed regarding its measured outcomes against other species like C. glabrata. Research is ongoing to address the potential for fungal organisms to develop reduced susceptibility. Data for certain groups remain insufficient, and research continues to explore whether findings from research apply consistently across all subgroups.

Key Studies & References

  1. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America (IDSA)
  2. Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by IDSA
  3. Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion - Frontiers
  4. Label: FLUCONAZOLE tablet - DailyMed - NIH (Summary of Product Characteristics information)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Fluconazole Evolugen (FAQ)

Q: Why is Fluconazole Evolugen sometimes prescribed as a single dose?

According to official product information, a single dose is the regimen typically studied for localized infections, such as acute vaginal candidiasis. This dosage reflects the regimen studied in clinical trials to address these specific conditions.


Q: How quickly should a person expect Fluconazole Evolugen to start working?

Studies and official information indicate that symptom improvement may begin relatively quickly, often within 24 hours to a few days for localized infections. The drug is described as having a mechanism that begins acting soon after administration, though individual response times may vary.


Q: How long does the effect of Fluconazole Evolugen usually last after taking it?

Official pharmacological data indicates that the medicine has a long mean half-life of approximately 30 hours. This extended period means that the active medicine remains in the body for several days, supporting its use in either a single-dose regimen or once-daily dosing for multi-day treatments.


Q: Are there specific signs that indicate a side effect is serious and requires attention?

Official documents state that serious adverse reactions, though rare, can occur. Specific signs highlighted include severe skin changes, such as a spreading rash, peeling skin, or fever (potential signs of Stevens-Johnson syndrome), or severe liver issues. Reports of dizziness or palpitations are noted as signs associated with serious risks and should be reported.


Q: Can taking Fluconazole Evolugen affect the effectiveness of birth control pills?

Official drug interaction studies indicate that Fluconazole Evolugen can cause an increase in the plasma concentrations of certain active components found in oral contraceptives, such as ethinyl estradiol. This potential pharmacokinetic interaction is documented in the drug's profile.


Q: Are there any known interactions between Fluconazole Evolugen and herbal supplements?

Regulatory documents focus mainly on prescription drug interactions and do not provide specific guidance on most common herbal supplements. However, the medicine is a strong enzyme inhibitor of CYP2C9 and CYP3A4. It is recognized that any co-administered substance metabolized by these enzymes may potentially have its concentrations altered.


Q: Can Fluconazole Evolugen be used by children, and is it available in different forms for them?

Official regulatory indications permit the use of this medicine in pediatric populations for treating specific infections. To facilitate administration, the drug is available in multiple forms, including an oral suspension powder which is often utilized for children.


Q: Is Fluconazole Evolugen safe for use in older adults?

Use in older adults is generally permitted under specific conditions, but official guidance specifies caution. Because reduced kidney function is common in this population, which can slow the medicine's clearance from the body, the need for a dosage adjustment is noted.


Q: Is it safe to breastfeed while taking Fluconazole Evolugen?

Official information describes that the medicine passes into breast milk. Consequently, breastfeeding is generally not recommended, particularly when the mother is taking high or prolonged doses, and the potential risk to the infant is a key consideration in the official profile.


Q: What are the official restrictions for people who have kidney problems?

Official documents indicate that patients with impaired kidney function require restricted use of the medication. The need for a dose adjustment to the maintenance regimen is noted in the official profile due to the potential for drug accumulation, as the drug is primarily cleared through the kidneys.


Q: Does Fluconazole Evolugen cause dizziness or drowsiness that affects driving?

Official documents report dizziness and seizures as uncommon potential side effects of the medicine. The occurrence of these effects is associated with cautions regarding performing activities requiring full mental alertness, such as driving or operating heavy machinery.


Q: Are there specific warnings about sunlight exposure while taking this medicine?

While the regulatory label details the risk of severe dermatologic reactions, it does not contain explicit general warnings about photosensitivity or increased sensitivity to sun exposure.


Q: What's the difference between Fluconazole Evolugen and other antifungal medicines?

Fluconazole Evolugen belongs to the triazole class of antifungal agents. Official information describes its mechanism as selectively inhibiting a specific fungal enzyme, 14alpha-demethylase, to disrupt the synthesis of ergosterol, which distinguishes its action from many other classes of antifungal drugs.


Q: Does Fluconazole Evolugen treat all types of fungal infections?

Official indications state that the medicine is approved only for specific fungal infections caused by organisms proven to be susceptible to it. These generally include certain species of Candida and Cryptococcus, meaning it is not indicated for infections caused by non-susceptible fungi.


Q: Are there any common reasons why Fluconazole Evolugen might not work for someone?

A primary factor for a lack of measured outcome or benefit, according to official microbiology data, is that the infection is caused by an organism that is naturally resistant or has developed resistance. Examples of less susceptible organisms include certain strains of Candida glabrata or Candida krusei.


Q: What kind of foods or drinks might interact with Fluconazole Evolugen?

Official regulatory documents state that the oral medicine can be taken with or without food since its absorption is not affected. However, the label advises caution regarding the co-administration of alcohol due to the potential for an increased risk of liver damage.


Q: Is the medication absorbed differently if you take it in liquid versus tablet form?

Bioequivalence studies, as detailed in the official product information, have confirmed that the oral tablet and the oral suspension (liquid) forms are absorbed similarly. This means the bioavailability of both oral forms is consistently high compared to intravenous administration.


Q: What are the official guidelines regarding using Fluconazole Evolugen if you have diabetes?

Official warnings advise caution if the patient is using sulfonylurea anti-diabetic medications, such as glyburide or glipizide. This combination may increase the concentration of the anti-diabetic drug in the body, which could potentially lead to low blood sugar (hypoglycemia).


Q: Are there specific populations where studies show different outcomes?

Official pharmacokinetic data shows that the rate at which the body processes the drug is distinct in specific groups, such as infants and older adults, compared to younger adults. These differences in drug clearance are the basis for noting the need for specific dose adjustments in these populations.


Q: Can Fluconazole Evolugen be used for skin infections, or is it only for internal use?

While the medicine is highly effective for systemic and internal infections, official indications confirm it is also used for certain superficial infections. Its ability to penetrate the skin and nail beds makes it suitable for treating those specific types of fungal infections.


Q: Is it considered a broad-spectrum antifungal?

Official information describes the medicine as active against a wide array of clinically significant fungal pathogens. This profile suggests a broad coverage within its specific class of triazole antifungals, effective against susceptible species of Candida and Cryptococcus.


Q: Are there any official restrictions on using Fluconazole Evolugen with certain psychiatric medications?

Official restrictions caution against co-administration with any medication known to prolong the QT interval, which includes certain psychiatric drugs. This warning is due to the documented risk of severe cardiac events when these drugs are used together.


Q: Does Fluconazole Evolugen have any known cosmetic side effects like hair loss?

While the most common and serious adverse reactions are detailed in clinical trial data, official post-marketing surveillance reports have also included less common cosmetic side effects, such as hair loss (medically termed alopecia).


Q: Is it possible to develop an allergy to Fluconazole Evolugen after using it previously?

Yes, official documents confirm that hypersensitivity reactions, including serious allergic reactions like anaphylaxis, have been reported in patients. Official guidance notes that the medication should be discontinued if any signs of hypersensitivity develop, regardless of prior use.


Q: What happens if a person misses a dose of Fluconazole Evolugen?

Official information indicates that a missed dose may be taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped, and the patient should simply continue with their regular schedule without attempting to take a double dose.

Advertisements

How should Fluconazole Evolugen be stored and disposed of?

How to Store and Dispose of Fluconazole

The storage requirements for Fluconazole are defined by its form. Tablets and the dry powder must be stored at temperatures below 30°C (86°F), protected from light and moisture, and kept in the original, tightly closed container.


Handling and Stability

Once the powder is mixed, the reconstituted oral suspension must be stored between 5°C and 30°C (41°F and 86°F) and must not be frozen. Any unused suspension must be discarded after 14 days.


Safety and Disposal

All forms of the medicine must be stored out of the sight and reach of children.

Expired or unused Fluconazole must be disposed of according to specific procedures. Do not flush the medicine down the toilet or pour it into a drain unless instructed by an authorized take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fluconazole Evolugen found in:

A-Z Index: